FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sathibalan Ponniah

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Procedures

Immunotherapy

Concepts & Ideas

Treatment Outcome

Co-author Network

Publications

TOP 3
Elizabeth A Mittendorf; Ritesh Patil; Sathibalan Ponniah; Alan K Sears; Alexander Stojadinovic; Linda C Benavides; Guy T Clifton; Kevin S Clive; Jeremy D Gates; Jarrod P Holmes; George E Peoples
Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
Kevin S Clive; Jarrod P Holmes; George E Peoples; Sathibalan Ponniah; Josh A Tyler; G Travis Clifton; Elizabeth A Mittendorf
The GP2 peptide: a HER2/neu-based breast cancer vaccine.
Alan K Sears; Nathan M Shumway; David C Van Echo; Sonia A Perez; Sathibalan Ponniah; Constantin N Baxevanis; Linda C Benavides; Mark G Carmichael; Guy T Clifton; Kevin S Clive; Jeremy D Gates; Jarrod P Holmes; Elizabeth A Mittendorf; Michael Papamichail; George E Peoples
AE37: a novel T-cell-eliciting vaccine for breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sathibalan Ponniah (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Elizabeth A Mittendorf; Ritesh Patil; Sathibalan Ponniah; Alan K Sears; Alexander Stojadinovic; Linda C Benavides; Guy T Clifton; Kevin S Clive; Jeremy D Gates; Jarrod P Holmes; George E Peoples
Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
Cancer 2012;118(10):2594-602.
2012: Kevin S Clive; Jarrod P Holmes; George E Peoples; Sathibalan Ponniah; Josh A Tyler; G Travis Clifton; Elizabeth A Mittendorf
The GP2 peptide: a HER2/neu-based breast cancer vaccine.
Journal of surgical oncology 2012;105(5):452-8.
2011: Alan K Sears; Nathan M Shumway; David C Van Echo; Sonia A Perez; Sathibalan Ponniah; Constantin N Baxevanis; Linda C Benavides; Mark G Carmichael; Guy T Clifton; Kevin S Clive; Jeremy D Gates; Jarrod P Holmes; Elizabeth A Mittendorf; Michael Papamichail; George E Peoples
AE37: a novel T-cell-eliciting vaccine for breast cancer.
Expert opinion on biological therapy 2011;11(11):1543-50.
2011: Linda C Benavides; Alan K Sears; Jeremy D Gates; Guy T Clifton; Kevin S Clive; Mark G Carmichael; Jarrod P Holmes; Elizabeth A Mittendorf; Sathibalan Ponniah; George E Peoples
Comparison of different HER2/neu vaccines in adjuvant breast cancer trials: implications for dosing of peptide vaccines.
Expert review of vaccines 2011;10(2):201-10.
2011: Guy T Clifton; Kevin S Clive; Jarrod P Holmes; Constantine G Ioannides; Elizabeth A Mittendorf; Sathibalan Ponniah; Alan K Sears; George E Peoples
Folate receptor α: a storied past and promising future in immunotherapy.
Human vaccines 2011;7(2):183-90.
2011: Jarrod P Holmes; Guy T Clifton; Ritesh Patil; Linda C Benavides; Jeremy D Gates; Alexander Stojadinovic; Elizabeth A Mittendorf; Sathibalan Ponniah; George E Peoples
Use of booster inoculations to sustain the clinical effect of an adjuvant breast cancer vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
Cancer 2011;117(3):463-71.
2010: Jeremy D Gates; Guy T Clifton; Linda C Benavides; Alan K Sears; Mark G Carmichael; Matthew Hueman; Jarrod P Holmes; Yusuf H Jama; Mohamed Mursal; Athina Zacharia; Kathy Ciano; Steven Khoo; Alexander Stojadinovic; Sathibalan Ponniah; George E Peoples
Circulating regulatory T cells (CD4+CD25+FOXP3+) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/neu (AE37) peptide.
Vaccine 2010;28(47):7476-82.
2010: Travis Clifton; Jarrod P Holmes; Diane Papay; Jennifer A Pappas; Maureen Pavlik; Sathibalan Ponniah; George E Peoples
Cancer Vaccine Development Program collaborations.
Military medicine 2010;175(7 Suppl):54-6.
2010: Kevin S Clive; Josh A Tyler; G Travis Clifton; Jarrod P Holmes; Elizabeth A Mittendorf; Sathibalan Ponniah; George E Peoples
Use of GM-CSF as an adjuvant with cancer vaccines: beneficial or detrimental?
Expert review of vaccines 2010;9(5):519-25.
2010: Ritesh Patil; Guy T Clifton; Jarrod P Holmes; Asna Amin; Mark G Carmichael; Jeremy D Gates; Linda H Benavides; Matthew Hueman; Sathibalan Ponniah; George E Peoples
Clinical and immunologic responses of HLA-A3+ breast cancer patients vaccinated with the HER2/neu-derived peptide vaccine, E75, in a phase I/II clinical trial.
Journal of the American College of Surgeons 2010;210(2):140-7.
2010: Mark G Carmichael; Linda C Benavides; Jarrod P Holmes; Jeremy D Gates; Elizabeth A Mittendorf; Sathibalan Ponniah; George E Peoples
Results of the first phase 1 clinical trial of the HER-2/neu peptide (GP2) vaccine in disease-free breast cancer patients: United States Military Cancer Institute Clinical Trials Group Study I-04.
Cancer 2010;116(2):292-301.
2010: Ahmed A Mohamed; Shyh-Han Tan; Natallia Mikhalkevich; Sathibalan Ponniah; Valeri Vasioukhin; Charles J Bieberich; Isabell A Sesterhenn; Albert Dobi; Shiv Srivastava; Taduru L Sreenath
Ets family protein, erg expression in developing and adult mouse tissues by a highly specific monoclonal antibody.
Journal of Cancer 2010;1():197-208.
2009: Linda C Benavides; Jeremy D Gates; Mark G Carmichael; Ritesh Patil; Ritesh Patel; Jarrod P Holmes; Matthew Hueman; Elizabeth A Mittendorf; Dianna Craig; Alexander Stojadinovic; Sathibalan Ponniah; George E Peoples
The impact of HER2/neu expression level on response to the E75 vaccine: from U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(8):2895-904.
2009: Nathan M Shumway; Nuhad Ibrahim; Sathibalan Ponniah; George E Peoples; James L Murray
Therapeutic breast cancer vaccines: a new strategy for early-stage disease.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 2009;23(5):277-87.
2008: Asna Amin; Linda C Benavides; Jarrod P Holmes; Jeremy D Gates; Mark G Carmichael; Matthew Hueman; Elizabeth A Mittendorf; Catherine E Storrer; Yusuf H Jama; Dianna Craig; Alexander Stojadinovic; Sathibalan Ponniah; George E Peoples
Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
Cancer immunology, immunotherapy : CII 2008;57(12):1817-25.
2008: Jarrod P Holmes; Jeremy D Gates; Linda C Benavides; Matthew Hueman; Mark G Carmichael; Ritesh Patil; Dianna Craig; Elizabeth A Mittendorf; Alexander Stojadinovic; Sathibalan Ponniah; George E Peoples
Optimal dose and schedule of an HER-2/neu (E75) peptide vaccine to prevent breast cancer recurrence: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
Cancer 2008;113(7):1666-75.
2008: Elizabeth A Mittendorf; Jarrod P Holmes; Sathibalan Ponniah; George E Peoples
The E75 HER2/neu peptide vaccine.
Cancer immunology, immunotherapy : CII 2008;57(10):1511-21.
2008: J D Gates; L C Benavides; Alexander Stojadinovic; Elizabeth A Mittendorf; J P Holmes; M G Carmichael; S McCall; A L Milford; G A Merrill; Sathibalan Ponniah; George E Peoples
Monitoring circulating tumor cells in cancer vaccine trials.
Human vaccines 2008;4(5):389-92.
2008: Jarrod P Holmes; Linda C Benavides; Jeremy D Gates; Mark G Carmichael; Matthew Hueman; Elizabeth A Mittendorf; James L Murray; Asna Amin; Dianna Craig; Eric von Hofe; Sathibalan Ponniah; George E Peoples
Results of the first phase I clinical trial of the novel II-key hybrid preventive HER-2/neu peptide (AE37) vaccine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(20):3426-33.
2008: George E Peoples; Jarrod P Holmes; Matthew Hueman; Elizabeth A Mittendorf; Asna Amin; Steven Khoo; Zia A Dehqanzada; Jennifer M Gurney; Michael M Woll; Gayle B Ryan; Catherine E Storrer; Dianna Craig; Constantin G Ioannides; Sathibalan Ponniah
Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast cancer patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(3):797-803.
2007: Alexander Stojadinovic; Elizabeth A Mittendorf; Jarrod P Holmes; Asna Amin; Matthew Hueman; Sathibalan Ponniah; George E Peoples
Quantification and phenotypic characterization of circulating tumor cells for monitoring response to a preventive HER2/neu vaccine-based immunotherapy for breast cancer: a pilot study.
Annals of surgical oncology 2007;14(12):3359-68.
2007: Alexander Stojadinovic; Jeffrey A Hooke; Craig Shriver; Aviram Nissan; Albert J Kovatich; Tzu-Cheg Kao; Sathibalan Ponniah; George E Peoples; Maria Moroni
HYOU1/Orp150 expression in breast cancer.
Medical science monitor : international medical journal of experimental and clinical research 2007;13(11):BR231-239.
2007: Carlyle Hamsher; Anna M Smith; Zia A Dehqanzada; Steven Khoo; Sathibalan Ponniah; George E Peoples; Maria Moroni
Pattern of serum immunoreactivity against breast cancer cell lysates may predict severity of disease in breast cancer patients.
Cancer immunology, immunotherapy : CII 2007;56(11):1711-21.
2007: Zia A Dehqanzada; Catherine E Storrer; Matthew Hueman; Rebecca J Foley; Katie A Harris; Yusuf H Jama; Craig Shriver; Sathibalan Ponniah; George E Peoples
Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex technology.
Oncology reports 2007;17(3):687-94.
2007: Matthew Hueman; Alexander Stojadinovic; Catherine E Storrer; Zia A Dehqanzada; Jennifer M Gurney; Craig Shriver; Sathibalan Ponniah; George E Peoples
Analysis of naïve and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/neu peptide (E75) and GM-CSF vaccine.
Cancer immunology, immunotherapy : CII 2007;56(2):135-46.
2006: Elizabeth A Mittendorf; Catherine E Storrer; Craig Shriver; Sathibalan Ponniah; George E Peoples
Investigating the combination of trastuzumab and HER2/neu peptide vaccines for the treatment of breast cancer.
Annals of surgical oncology 2006;13(8):1085-98.
2006: Matthew Hueman; Alexander Stojadinovic; Catherine E Storrer; Rebecca J Foley; Jennifer M Gurney; Craig Shriver; Sathibalan Ponniah; George E Peoples
Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.
Breast cancer research and treatment 2006;98(1):17-29.
2006: Elizabeth A Mittendorf; Catherine E Storrer; Rebecca J Foley; Katie Harris; Yusuf H Jama; Craig Shriver; Sathibalan Ponniah; George E Peoples
Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial.
Cancer 2006;106(11):2309-17.
2006: Steven Khoo; Sathibalan Ponniah; George E Peoples
HER2/neu vaccines in breast cancer.
Women's health (London, England) 2006;2(2):217-23.
2006: Elizabeth A Mittendorf; Jennifer M Gurney; Catherine E Storrer; Craig Shriver; Sathibalan Ponniah; George E Peoples
Vaccination with a HER2/neu peptide induces intra- and inter-antigenic epitope spreading in patients with early stage breast cancer.
Surgery 2006;139(3):407-18.
2006: Zia A Dehqanzada; Catherine E Storrer; Matthew Hueman; Rebecca J Foley; Katie A Harris; Yusuf H Jama; Tzu-Cheg Kao; Craig Shriver; Sathibalan Ponniah; George E Peoples
Correlations between serum monocyte chemotactic protein-1 levels, clinical prognostic factors, and HER-2/neu vaccine-related immunity in breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(2):478-86.
2005: George E Peoples; Jennifer M Gurney; Matthew Hueman; Michael M Woll; Gayle B Ryan; Catherine E Storrer; Christine Fisher; Craig Shriver; Constantin G Ioannides; Sathibalan Ponniah
Clinical trial results of a HER2/neu (E75) vaccine to prevent recurrence in high-risk breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7536-45.
2005: Matthew Hueman; Zia A Dehqanzada; Thomas E Novak; Jennifer M Gurney; Michael M Woll; Gayle B Ryan; Catherine E Storrer; Christine Fisher; David G McLeod; Constantin G Ioannides; Sathibalan Ponniah; George E Peoples
Phase I clinical trial of a HER-2/neu peptide (E75) vaccine for the prevention of prostate-specific antigen recurrence in high-risk prostate cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(20):7470-9.
2005: Elizabeth A Mittendorf; Catherine E Storrer; Craig Shriver; Sathibalan Ponniah; George E Peoples
Evaluation of the CD107 cytotoxicity assay for the detection of cytolytic CD8+ cells recognizing HER2/neu vaccine peptides.
Breast cancer research and treatment 2005;92(1):85-93.
2004: Michael M Woll; Christine M Fisher; Gayle B Ryan; Jennifer M Gurney; Catherine E Storrer; Constantin G Ioannides; Craig Shriver; Judd W Moul; David G McLeod; Sathibalan Ponniah; George E Peoples
Direct measurement of peptide-specific CD8+ T cells using HLA-A2:Ig dimer for monitoring the in vivo immune response to a HER2/neu vaccine in breast and prostate cancer patients.
Journal of clinical immunology 2004;24(4):449-61.
2004: Elena N Klyushnenkova; Sathibalan Ponniah; Alejandro Rodriguez; James Kodak; Dean L Mann; Alexander Langerman; Michael I Nishimura; Richard B Alexander
CD4 and CD8 T-lymphocyte recognition of prostate specific antigen in granulomatous prostatitis.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2004;27(2):136-46.
2000: Sathibalan Ponniah; I Arah; Richard B Alexander
PSA is a candidate self-antigen in autoimmune chronic prostatitis/chronic pelvic pain syndrome.
The Prostate 2000;44(1):49-54.
1999: K A Berlyn; Sathibalan Ponniah; Sanford A Stass; JG Malone; G Hamlin-Green; J K Lim; Michele Cottler-Fox; Guido Tricot; Richard B Alexander; Dean L Mann; Robert W Malone
Developing dendritic cell polynucleotide vaccination for prostate cancer immunotherapy.
Journal of biotechnology 1999;73(2-3):155-79.
1998: Richard B Alexander; Sathibalan Ponniah; Jeffrey D Hasday; J Richard Hebel
Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome.
Urology 1998;52(5):744-9.
1997: Richard B Alexander; F Brady; Sathibalan Ponniah
Autoimmune prostatitis: evidence of T cell reactivity with normal prostatic proteins.
Urology 1997;50(6):893-9.
1997: E J Friedman; C R Orth; K A Brewton; Sathibalan Ponniah; Richard B Alexander
Cryosurgical ablation of the normal ventral prostate plus adjuvant does not protect Copenhagen rats from Dunning prostatic adenocarcinoma challenge.
The Journal of urology 1997;158(4):1585-8.